Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical manageme...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2016.
|
| Edition: | 1st ed. 2016. |
| Series: | Advances in Experimental Medicine and Biology,
890 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-319-24932-2 |